Personnel

Cell Genesys announces management change

Published in Oncology Business Week, December 3rd, 2006

Cell Genesys, Inc. (CEGE) announced that Joseph J. Vallner, PhD, the company's president and chief operating officer, has resigned to become the chief executive officer of an early-stage, private biotechnology company.

Vallner's responsibilities will be assumed by Stephen A. Sherwin, MD, the company's chairman and chief executive officer, and other members of the company's executive management team. There are no immediate plans to hire a replacement for Vallner.

"I would like to thank Joe for his many important contributions to Cell Genesys during the past several years," said Dr. Sherwin. "Under Joe's leadership, Cell Genesys has continued to evolve...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2006-12-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry